QL
KNSA icon

Quarry LP’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quarry LP’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-110
Closed -$5.3K – 2479
2026
Q1 		$5.3K Sell
110
-160
-59% -$7.09K ﹤0.01% 966
2025
Q4 		$11.1K Sell
270
-856
-76% -$34.3K ﹤0.01% 1348
2025
Q3 		$43.7K Buy
+1,126
New +$36.6K 0.01% 920
2024
Q4 		– Sell
-2,000
Closed -$50K – 1830
2024
Q3 		$50K Buy
+2,000
New +$48.7K 0.01% 734

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Quarry LP's KNSA Position: Q2 2026 in Review

Quarry LP sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2026, closing a stake of 110 shares — an estimated $5.3K sold.

Quarry LP first reported a position in KNSA in Q3 2024 and held it in 4 quarters. The position peaked at $50K in Q3 2024. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Quarry LP reported no remaining Kiniksa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Quarry LP sold 110 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $5.3K.
  • Quarry LP first reported a position in Kiniksa Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Quarry LP's Kiniksa Pharmaceuticals position peaked at $50K in Q3 2024.
  • 267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.